These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

905 related items for PubMed ID: 25818681

  • 1. Regulation of peroxisome proliferator-activated receptors (PPAR) α and -γ of rat brain astrocytes in the course of activation by toll-like receptor agonists.
    Chistyakov DV, Aleshin SE, Astakhova AA, Sergeeva MG, Reiser G.
    J Neurochem; 2015 Jul; 134(1):113-24. PubMed ID: 25818681
    [Abstract] [Full Text] [Related]

  • 2. Regulation of peroxisome proliferator-activated receptor β/δ expression and activity levels by toll-like receptor agonists and MAP kinase inhibitors in rat astrocytes.
    Chistyakov DV, Aleshin S, Sergeeva MG, Reiser G.
    J Neurochem; 2014 Aug; 130(4):563-74. PubMed ID: 24806616
    [Abstract] [Full Text] [Related]

  • 3. Toll-like receptors control p38 and JNK MAPK signaling pathways in rat astrocytes differently, when cultured in normal or high glucose concentrations.
    Chistyakov DV, Azbukina NV, Astakhova AA, Polozhintsev AI, Sergeeva MG, Reiser G.
    Neurochem Int; 2019 Dec; 131():104513. PubMed ID: 31369777
    [Abstract] [Full Text] [Related]

  • 4. Peroxisome proliferator-activated receptor (PPAR)-gamma positively controls and PPARalpha negatively controls cyclooxygenase-2 expression in rat brain astrocytes through a convergence on PPARbeta/delta via mutual control of PPAR expression levels.
    Aleshin S, Grabeklis S, Hanck T, Sergeeva M, Reiser G.
    Mol Pharmacol; 2009 Aug; 76(2):414-24. PubMed ID: 19483106
    [Abstract] [Full Text] [Related]

  • 5. PPAR activation has dichotomous control on the expression levels of cytosolic and secretory phospholipase A2 in astrocytes; inhibition in naïve, untreated cells and enhancement in LPS-stimulated cells.
    Sergeeva MG, Aleshin SE, Grabeklis S, Reiser G.
    J Neurochem; 2010 Oct; 115(2):399-410. PubMed ID: 20670373
    [Abstract] [Full Text] [Related]

  • 6. Peroxisome proliferator-activated receptor (PPAR)β/δ, a possible nexus of PPARα- and PPARγ-dependent molecular pathways in neurodegenerative diseases: Review and novel hypotheses.
    Aleshin S, Strokin M, Sergeeva M, Reiser G.
    Neurochem Int; 2013 Oct; 63(4):322-30. PubMed ID: 23811400
    [Abstract] [Full Text] [Related]

  • 7. Statins activate peroxisome proliferator-activated receptor gamma through extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase-dependent cyclooxygenase-2 expression in macrophages.
    Yano M, Matsumura T, Senokuchi T, Ishii N, Murata Y, Taketa K, Motoshima H, Taguchi T, Sonoda K, Kukidome D, Takuwa Y, Kawada T, Brownlee M, Nishikawa T, Araki E.
    Circ Res; 2007 May 25; 100(10):1442-51. PubMed ID: 17463321
    [Abstract] [Full Text] [Related]

  • 8. Comparison of PPAR Ligands as Modulators of Resolution of Inflammation, via Their Influence on Cytokines and Oxylipins Release in Astrocytes.
    Chistyakov DV, Astakhova AA, Goriainov SV, Sergeeva MG.
    Int J Mol Sci; 2020 Dec 16; 21(24):. PubMed ID: 33339154
    [Abstract] [Full Text] [Related]

  • 9. Peroxisome proliferator-activated receptor β/δ (PPARβ/δ) protects against ceramide-induced cellular toxicity in rat brain astrocytes and neurons by activation of ceramide kinase.
    Aleshin S, Reiser G.
    Mol Cell Neurosci; 2014 Mar 16; 59():127-34. PubMed ID: 24513118
    [Abstract] [Full Text] [Related]

  • 10. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
    Moulin D, Bianchi A, Boyault S, Sebillaud S, Koufany M, Francois M, Netter P, Jouzeau JY, Terlain B.
    Arthritis Rheum; 2005 Mar 16; 52(3):759-69. PubMed ID: 15751073
    [Abstract] [Full Text] [Related]

  • 11. The transcriptional coactivator peroxisome proliferator activated receptor (PPAR)gamma coactivator-1 alpha and the nuclear receptor PPAR alpha control the expression of glycerol kinase and metabolism genes independently of PPAR gamma activation in human white adipocytes.
    Mazzucotelli A, Viguerie N, Tiraby C, Annicotte JS, Mairal A, Klimcakova E, Lepin E, Delmar P, Dejean S, Tavernier G, Lefort C, Hidalgo J, Pineau T, Fajas L, Clément K, Langin D.
    Diabetes; 2007 Oct 16; 56(10):2467-75. PubMed ID: 17646210
    [Abstract] [Full Text] [Related]

  • 12. Peroxisome proliferator-activated receptor gamma1 expression is diminished in human osteoarthritic cartilage and is downregulated by interleukin-1beta in articular chondrocytes.
    Afif H, Benderdour M, Mfuna-Endam L, Martel-Pelletier J, Pelletier JP, Duval N, Fahmi H.
    Arthritis Res Ther; 2007 Oct 16; 9(2):R31. PubMed ID: 17386086
    [Abstract] [Full Text] [Related]

  • 13. Agonists of peroxisome proliferators-activated receptors (PPAR) alpha, beta/delta or gamma reduce transforming growth factor (TGF)-beta-induced proteoglycans' production in chondrocytes.
    Poleni PE, Bianchi A, Etienne S, Koufany M, Sebillaud S, Netter P, Terlain B, Jouzeau JY.
    Osteoarthritis Cartilage; 2007 May 16; 15(5):493-505. PubMed ID: 17140817
    [Abstract] [Full Text] [Related]

  • 14. Propofol Inhibits Lipopolysaccharide-Induced Inflammatory Responses in Spinal Astrocytes via the Toll-Like Receptor 4/MyD88-Dependent Nuclear Factor-κB, Extracellular Signal-Regulated Protein Kinases1/2, and p38 Mitogen-Activated Protein Kinase Pathways.
    Zhou CH, Zhu YZ, Zhao PP, Xu CM, Zhang MX, Huang H, Li J, Liu L, Wu YQ.
    Anesth Analg; 2015 Jun 16; 120(6):1361-8. PubMed ID: 25695672
    [Abstract] [Full Text] [Related]

  • 15. Peroxisome proliferator-activated receptor (PPAR) alpha and PPARbeta/delta, but not PPARgamma, modulate the expression of genes involved in cardiac lipid metabolism.
    Gilde AJ, van der Lee KA, Willemsen PH, Chinetti G, van der Leij FR, van der Vusse GJ, Staels B, van Bilsen M.
    Circ Res; 2003 Mar 21; 92(5):518-24. PubMed ID: 12600885
    [Abstract] [Full Text] [Related]

  • 16. Regulation of cigarette smoke-induced toll-like receptor 4 expression by peroxisome proliferator-activated receptor-gamma agonists in bronchial epithelial cells.
    Yin Y, Hou G, Li ER, Wang QY, Kang J.
    Respirology; 2013 Nov 21; 18 Suppl 3():30-9. PubMed ID: 24188201
    [Abstract] [Full Text] [Related]

  • 17. Inflammatory reaction versus endogenous peroxisome proliferator-activated receptors expression, re-exploring secondary organ complications of spontaneously hypertensive rats.
    Sun L, Ke Y, Zhu CY, Tang N, Tian DK, Gao YH, Zheng JP, Bian K.
    Chin Med J (Engl); 2008 Nov 20; 121(22):2305-11. PubMed ID: 19080338
    [Abstract] [Full Text] [Related]

  • 18. Peroxisome proliferator-activated receptors-α and -γ, and cAMP-mediated pathways, control retinol-binding protein-4 gene expression in brown adipose tissue.
    Rosell M, Hondares E, Iwamoto S, Gonzalez FJ, Wabitsch M, Staels B, Olmos Y, Monsalve M, Giralt M, Iglesias R, Villarroya F.
    Endocrinology; 2012 Mar 20; 153(3):1162-73. PubMed ID: 22253419
    [Abstract] [Full Text] [Related]

  • 19. Oxidized low density lipoprotein activates peroxisome proliferator-activated receptor-alpha (PPARalpha) and PPARgamma through MAPK-dependent COX-2 expression in macrophages.
    Taketa K, Matsumura T, Yano M, Ishii N, Senokuchi T, Motoshima H, Murata Y, Kim-Mitsuyama S, Kawada T, Itabe H, Takeya M, Nishikawa T, Tsuruzoe K, Araki E.
    J Biol Chem; 2008 Apr 11; 283(15):9852-62. PubMed ID: 18208815
    [Abstract] [Full Text] [Related]

  • 20. Reduced expression of 11β-hydroxysteroid dehydrogenase type 2 in preeclamptic placentas is associated with decreased PPARγ but increased PPARα expression.
    He P, Chen Z, Sun Q, Li Y, Gu H, Ni X.
    Endocrinology; 2014 Jan 11; 155(1):299-309. PubMed ID: 24169559
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.